Linked Data API

Show Search Form

Search Results

1186531
star this property registered interest false more like this
star this property date less than 2020-03-19more like thismore than 2020-03-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Health Services: Technology remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will make an assessment of the implications for his policies on (a) improving access to innovative medicines and (b) fostering the life sciences sector of the National Institute for Health and Care Excellence health technology evaluation review. more like this
star this property tabling member constituency Reigate more like this
star this property tabling member printed
Crispin Blunt more like this
star this property uin 32038 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2020-05-29more like thismore than 2020-05-29
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is reviewing its methods for the development of technology appraisal and highly specialised technology recommendations in line with the commitment in the 2019 voluntary scheme for branded medicines pricing and access. The scheme also states the Government’s expectations for the review as follows: ‘“The Department expects that any future changes to NICE methods and processes would respond to the new types of innovation coming to the market, be consistent with improving the health gain achieved by spending on new innovative medicines, and support faster adoption of the most clinically and cost effective medicines.”’</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 32039 more like this
star this property question first answered
remove filter
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
104
unstar this property label Biography information for Crispin Blunt more like this